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Growth hormone 27 2 8 a b s t r a c t 29 During manufacturing, therapeutic proteins may be exposed to ultraviolet (UV) radiation. Such exposure 30 is of concern because UV radiation may cause photooxidative damage to proteins, which in turn could 31 lead to physical changes such as aggregation and enhanced immunogenicity. We exposed murine growth 32 hormone (mGH) to controlled doses of UV radiation, and examined the resulting chemical, physical and 33 immunogenic changes in the protein. mGH chemical structure was analyzed by mass spectrometry after 34 UV irradiation. Photooxidation products detected by mass spectrometry included methionine sulfoxide 35 formed at Met [127] ments. Physical damage to UV-irradiated mGH was monitored by infrared spectrometry, chromato-39 graphic analyses, and particle counting by micro-flow imaging. UV radiation caused mGH to aggregate, 40 forming insoluble microparticles containing mGH with non-native secondary structure. When 41 administered subcutaneously to Balb/c or Nude Balb/c mice, UV-irradiated mGH provoked antibodies 42 that cross-reacted with unmodified mGH in a fashion consistent with a T-cell dependent immune 43 response. In wildtype Balb/c mice, titers for anti-mGH IgG 1 antibodies increased with increasing UV radi-44 ation doses. 45 
Introduction

51
Therapeutic proteins are known to aggregate in response to 52 common stresses that may be encountered throughout their prod-53 uct life cycle. Ultraviolet (UV) light is one such stress to which ther-54 apeutic proteins may be exposed during processing, storage and 55 consumer use. In addition, it has been proposed that biotechnology 56 products may be exposed to UV irradiation for viral decontamina-57 tion [1] . UV exposure can also occur during storage and consumer 58 use if products are not completely isolated from light. 59 Proteins may be chemically damaged when exposed to light (for [2] . In turn, chemically damaged protein molecules 62 may have a greater propensity to aggregate [3, 4] . Chemically 63 degraded proteins may be immunogenic [5, 6] and protein impuri-64 ties at levels <1% may induce immune responses [7] . Furthermore, 65 aggregated proteins have long been known to be immunogenic in 66 humans [8] [9] [10] [11] , and more recently aggregation of therapeutic pro-67 teins and immunogenicity has been associated in a number of 68 studies conducted in mice [7, 12, 13] . Another recent study [14] 69 showed that exposure of naive human peripheral blood mononu-70 clear cells to aggregated therapeutic antibodies stimulated their 71 innate immune response. 72 We hypothesize that exposure of therapeutic proteins to UV 73 light could lead not only to their photodegradation, but also to 74 aggregation and concomitant enhancements in their immunogenic 75 potential.
76
In this study, we exposed murine growth hormone (mGH) The wells were then drained and washed three times with PBS con- The stock mGH used in this study has a relatively low solubility 407 (ca. 1 mg/ml) and therefore could not be concentrated sufficiently 408 to obtain a high quality infrared spectrum of the soluble protein. 409 Because it has been reported that infrared spectra for native indicating perturbation of mGH secondary structure (Fig. 4) . A
432
On day 22, immune responses were more prevalent in both 433 mouse strains (Fig. 5b) . In the Balb/c mice, the IgG1 titers on day 
